GLP-1 agonists are increasingly being prescribed for weight reduction due to their proven ability to regulate appetite, delay gastric emptying, and improve metabolic health
Jessica Drummond 00:22:22 It depends on, like you said, the whole rest of it
it's a catastrophic error that can compromise your entire research project, rendering your data useless and wasting valuable resources
Any substantial weight loss (on a GLP-1 or not) sheds some lean mass alongside fat
It exhibits a pronounced stress-protective effect and reduces stress-induced metabolic and functional disorders in humans and animals exposed to various stressors
Further studies are needed to elucidate the predisposition of some variants toward certain clinical manifestations, particularly neonatal hyperbilirubinemia, and how some variants increase in severity when co-inherited with other blood- or bilirubin-related genetic disorders